Eckert & Ziegler Strahlen- und Medizintechnik AG - Asset Resilience Ratio
Eckert & Ziegler Strahlen- und Medizintechnik AG (EUZ) has an Asset Resilience Ratio of 0.02% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read EUZ total liabilities for a breakdown of total debt and financial obligations.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2013–2025)
This chart shows how Eckert & Ziegler Strahlen- und Medizintechnik AG's Asset Resilience Ratio has changed over time. See Eckert & Ziegler Strahlen- und Medizinte shareholders equity for net asset value and shareholders' equity analysis.
Liquid Assets Composition Over Time
This chart breaks down Eckert & Ziegler Strahlen- und Medizintechnik AG's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see market value of Eckert & Ziegler Strahlen- und Medizinte.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | €0.00 | 0% |
| Short-term Investments | €72.00K | 0.02% |
| Total Liquid Assets | €72.00K | 0.02% |
Asset Resilience Insights
- Limited Liquidity: Eckert & Ziegler Strahlen- und Medizintechnik AG maintains only 0.02% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Eckert & Ziegler Strahlen- und Medizintechnik AG Industry Peers by Asset Resilience Ratio
Compare Eckert & Ziegler Strahlen- und Medizintechnik AG's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
INKON Life Technology Co Ltd
SHE:300143 |
Medical Devices | 3.37% |
|
CareRay Digital Medical Technology Co Ltd
SHG:688607 |
Medical Devices | 16.21% |
|
Senseonics Holdings, Inc. Common Stock
NYSE MKT:SENS |
Medical Devices | 54.67% |
|
Universus Photo Imagings Limited
NSE:UNIVPHOTO |
Medical Devices | 30.97% |
|
HansBiomed Corporation
KQ:042520 |
Medical Devices | 9.13% |
|
Aligned Genetics Inc
KQ:238120 |
Medical Devices | 2.22% |
|
Heramed Ltd
AU:HMD |
Medical Devices | 0.83% |
|
Acarix A/S
ST:ACARIX |
Medical Devices | 37.81% |
Annual Asset Resilience Ratio for Eckert & Ziegler Strahlen- und Medizintechnik AG (2013–2025)
The table below shows the annual Asset Resilience Ratio data for Eckert & Ziegler Strahlen- und Medizintechnik AG.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-12-31 | 0.02% | €72.00K ≈ $84.18K |
€457.93 Million ≈ $535.36 Million |
-0.02pp |
| 2024-12-31 | 0.03% | €144.00K ≈ $168.35K |
€442.40 Million ≈ $517.21 Million |
-0.36pp |
| 2021-12-31 | 0.39% | €1.36 Million ≈ $1.59 Million |
€347.73 Million ≈ $406.53 Million |
+0.00pp |
| 2020-12-31 | 0.39% | €1.14 Million ≈ $1.33 Million |
€292.00 Million ≈ $341.38 Million |
+0.38pp |
| 2013-12-31 | 0.01% | €22.00K ≈ $25.72K |
€178.41 Million ≈ $208.58 Million |
-- |
About Eckert & Ziegler Strahlen- und Medizintechnik AG
Eckert & Ziegler SE manufactures and sells isotope technology components worldwide. It operates through two segments, Medical and Isotope Products. The company provides small implants for the treatment of prostate cancer seeds; and eye applicators based on ruthenium-106 and iodine-125 for the treatment of uveal melanomas; brain seed, HDR and brachytherapy; therapeutic and radiotherapy accessories… Read more